Numerous clinical studies supporting its benefits are both lauded and ridiculed with equal enthusiasm, seemingly depending upon the pre-existing opinion of the commentator. Clinical results simply don't seem to matter much, those opposing the drug's clinical use deriding the validity of existing studies and demanding standardization of dosages on the level of other pharmaceutical agents in order to take the matter seriously. Naysayers point to widespread reversion of patients to more potent street marijuana from medical marijuana and accuse proponents of the drug as simply attempting to make the drug available legally, viewing most evidence of efficacy as anecdotal. In chemotherapy patients, not only does THC reduce the nausea and vomiting, but it provides appetite stimulus to ameliorate wasting syndromes as a bonus side effect, especially valuable for AIDS patients. At the same time, favorable evidence continues to accrue as results are reported in such peer-reviewed publications as JAMA , Lancet , Annals of Internal Medicine , Journal of Clinical Pharmacology , and NEJM .
Governmental agencies continue to be similarly torn.
Though 34 states since 1978 have passed legislation to make marijuana available for medical purposes, mostly on an experimental basis, little such study has actually begun. I agent with no accepted medical value in treatment.